Literature DB >> 31198115

Computational Drug Repurposing: Classification of the Research Opportunities and Challenges.

Seyedeh Shaghayegh Sadeghi1, Mohammad Reza Keyvanpour2.   

Abstract

BACKGROUND: Drug repurposing has grown significantly in recent years. Research and innovation in drug repurposing are extremely popular due to its practical and explicit advantages. However, its adoption into practice is slow because researchers and industries have to face various challenges.
OBJECTIVE: As this field, there is a lack of a comprehensive platform for systematic identification for removing development limitations. This paper deals with a comprehensive classification of challenges in drug repurposing.
METHODS: Initially, a classification of various existing repurposing models is propounded. Next, the benefits of drug repurposing are summarized. Further, a categorization for computational drug repurposing shortcomings is presented. Finally, the methods are evaluated based on their strength to addressing the drawbacks.
RESULTS: This work can offer a desirable platform for comparing the computational repurposing methods by measuring the methods in light of these challenges.
CONCLUSION: A proper comparison could prepare guidance for a genuine understanding of methods. Accordingly, this comprehension of the methods will help researchers eliminate the barriers thereby developing and improving methods. Furthermore, in this study, we conclude why despite all the benefits of drug repurposing, it is not being done anymore. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Keywords:  Drug repurposing; benefit; challenges; computation repurposing; data mining; machine learning

Mesh:

Year:  2020        PMID: 31198115     DOI: 10.2174/1573409915666190613113822

Source DB:  PubMed          Journal:  Curr Comput Aided Drug Des        ISSN: 1573-4099            Impact factor:   1.606


  2 in total

1.  Increased lifespan, decreased mortality, and delayed cognitive decline in osteoarthritis.

Authors:  Anatoly L Mayburd; Ancha Baranova
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

2.  A Network-Based Drug Repurposing Method Via Non-Negative Matrix Factorization.

Authors:  Shagahyegh Sadeghi; Jianguo Lu; Alioune Ngom
Journal:  Bioinformatics       Date:  2021-12-07       Impact factor: 6.937

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.